Effect of Nano-Curcumin On Neoadjuvant Chemotherapy of Bladder Cancer Patients
Phase 2
- Conditions
- Bladder Cancer.Malignant neoplasm of bladder
- Registration Number
- IRCT20180226038875N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
patients with TCC of Bladder
ECOG performance of 0 or 1
candidate to receive neoadjuvant chemotherapy
Exclusion Criteria
Metastatic disease
age under 18 or over 80
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical complete response to chemotherapy. Timepoint: 4 weeks after completion of chemotherapy. Method of measurement: cystoscopy.
- Secondary Outcome Measures
Name Time Method